Aurobindo Pharma Ltd.
| BSE: 524804 | Sector: Health care |
| NSE: AUROPHARMA | ISIN Code: INE406A01037 |
| BSE 00:00 | 30 Nov | 468.10 |
1.50 (0.32%) |
OPEN
467.00 |
HIGH
470.95 |
LOW
463.95 |
| NSE 00:00 | 30 Nov | 467.35 |
0.75 (0.16%) |
OPEN
468.00 |
HIGH
470.95 |
LOW
464.00 |
| OPEN | 467.00 |
| PREVIOUS CLOSE | 466.60 |
| VOLUME | 49719 |
| 52-Week high | 742.25 |
| 52-Week low | 455.05 |
| P/E | 19.58 |
| Mkt Cap.(Rs cr) | 27,426 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Aurobindo Pharma Ltd. (AUROPHARMA) - Cash Flow
| Figures in Rs crore | 2022 | 2021 | 2020 |
| Opening Cash & Cash Equivalents | 383.58 | 67.35 | 68.70 |
| Net Cash From Operating Activities | 3726.71 | 2994.53 | 2201.38 |
| Net Cash Used In/from Investing Activities | -1614.54 | -2650.24 | -948.08 |
| Net Cash Used In/from Financing Activities | -2447.54 | -28.06 | -1254.65 |
| Net (decrease)/increase In Cash and Cash Equivalents |
-335.37 | 316.23 | -1.35 |
| Closing Cash & Cash Equivalents | 48.21 | 383.58 | 67.35 |
Quick Links for Aurobindo Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
